{"transactions":[{"id":4631804,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-10-03T00:05:16.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":271,"price":87.42,"value":23690.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":40725,"source":{"system":"sec-edgar","filing":"0001225208-26-008100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520826008100/doc4.xml","form_type":"4"}},{"id":713485,"issuer":{"id":31605,"kind":"organization","name":"OLAPLEX HOLDINGS, INC.","symbol":"OLPX"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T21:30:08.000Z","date":"2026-07-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":318418,"price":2.06,"value":655941.08,"ownership":{"direct":false,"nature":"By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation (\"Parent\"), and Margot Acquisition Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the \"Merger\" and, together with the other transactions contemplated by the Merger Agreement, the \"Transactions\"). At the effective time of the Merger (the \"Effective Time\"), each share of Common Stock of the Issuer (each, a \"Share\") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the \"Merger Consideration\"), without interest, subject to any withholding of taxes required by applicable law."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-297670","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000119312526297670/ownership.xml","form_type":"4"}},{"id":713484,"issuer":{"id":31605,"kind":"organization","name":"OLAPLEX HOLDINGS, INC.","symbol":"OLPX"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T21:30:08.000Z","date":"2026-07-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":640021,"price":2.06,"value":1318443.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"At the Effective Time, each award of restricted stock units covering Shares granted under the Issuer's 2021 Equity Incentive Plan, the Issuer's Amended & Restated 2020 Omnibus Equity Incentive Plan, or any other effective equity or equity-based incentive plan sponsored by the Issuer or its affiliates (each such award, a \"Company RSU Award\") that was outstanding immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company RSU Award, multiplied by (y) the Merger Consideration. The amount reported includes 294,118 Shares underlying the Reporting Person's Company RSU Awards, which were automatically cancelled and converted into the right to receive the Merger Consideration at the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation (\"Parent\"), and Margot Acquisition Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the \"Merger\" and, together with the other transactions contemplated by the Merger Agreement, the \"Transactions\"). At the effective time of the Merger (the \"Effective Time\"), each share of Common Stock of the Issuer (each, a \"Share\") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the \"Merger Consideration\"), without interest, subject to any withholding of taxes required by applicable law."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-297670","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000119312526297670/ownership.xml","form_type":"4"}},{"id":720421,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-02T20:15:33.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":265,"price":89.45,"value":23704.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":40229,"source":{"system":"sec-edgar","filing":"0001225208-26-006373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520826006373/doc4.xml","form_type":"4"}},{"id":781842,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-13T20:45:40.000Z","date":"2026-05-11","kind":"grant","planned":false,"acquired":true,"shares":2424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Annual director stock option grant under the issuer's incentive compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date."}],"balance_after":2424,"derivative":{"exercise_price":86.74,"expiration_date":"2034-05-11","underlying":"Common Stock","underlying_shares":2424},"source":{"system":"sec-edgar","filing":"0001225208-26-005233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520826005233/doc4.xml","form_type":"4"}},{"id":781841,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-13T20:45:40.000Z","date":"2026-05-11","kind":"grant","planned":false,"acquired":true,"shares":2075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan."}],"balance_after":39820,"source":{"system":"sec-edgar","filing":"0001225208-26-005233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520826005233/doc4.xml","form_type":"4"}},{"id":818513,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-04-03T20:04:05.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":266,"price":89.05,"value":23687.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":37665,"source":{"system":"sec-edgar","filing":"0001225208-26-004361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520826004361/doc4.xml","form_type":"4"}},{"id":949618,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-06T21:07:00.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":301,"price":78.66,"value":23676.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":37195,"source":{"system":"sec-edgar","filing":"0001225208-26-000334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520826000334/doc4.xml","form_type":"4"}},{"id":1026262,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-03T20:08:50.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":289,"price":82.13,"value":23735.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":36658,"source":{"system":"sec-edgar","filing":"0001225208-25-008429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520825008429/doc4.xml","form_type":"4"}},{"id":1066280,"issuer":{"id":31605,"kind":"organization","name":"OLAPLEX HOLDINGS, INC.","symbol":"OLPX"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-14T20:03:58.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":294118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the conditional right to receive one share of Common Stock. The RSUs will vest in full on the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":640021,"source":{"system":"sec-edgar","filing":"0001868726-25-000093","document":"wk-form4_1755201835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000186872625000093/wk-form4_1755201835.xml","form_type":"4"}},{"id":1097418,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-02T20:12:54.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":264,"price":89.91,"value":23736.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":36156,"source":{"system":"sec-edgar","filing":"0001225208-25-006334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520825006334/doc4.xml","form_type":"4"}},{"id":1150278,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-14T20:16:33.000Z","date":"2025-05-12","kind":"grant","planned":false,"acquired":true,"shares":2272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Annual director stock option grant under the issuer's incentive compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 12, 2025 grant date."}],"balance_after":2272,"derivative":{"exercise_price":89.14,"expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":2272},"source":{"system":"sec-edgar","filing":"0001225208-25-005088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520825005088/doc4.xml","form_type":"4"}},{"id":1150277,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-14T20:16:33.000Z","date":"2025-05-12","kind":"grant","planned":false,"acquired":true,"shares":2019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan."}],"balance_after":35768,"source":{"system":"sec-edgar","filing":"0001225208-25-005088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520825005088/doc4.xml","form_type":"4"}},{"id":1182112,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-03T20:15:26.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":231,"price":91.99,"value":21249.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":33688,"source":{"system":"sec-edgar","filing":"0001225208-25-004005","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520825004005/doc4.xml","form_type":"4"}},{"id":1313023,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-06T21:15:31.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":228,"price":93.18,"value":21245.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":33273,"source":{"system":"sec-edgar","filing":"0001225208-25-000337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520825000337/doc4.xml","form_type":"4"}},{"id":1344686,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T22:09:14.000Z","date":"2024-11-29","kind":"grant","planned":false,"acquired":true,"shares":18169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors."}],"balance_after":78400,"source":{"system":"sec-edgar","filing":"0001415889-24-028145","document":"form4-12032024_101210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588924028145/form4-12032024_101210.xml","form_type":"4"}},{"id":1358795,"issuer":{"id":31605,"kind":"organization","name":"OLAPLEX HOLDINGS, INC.","symbol":"OLPX"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-19T21:04:17.000Z","date":"2024-11-18","kind":"purchase","planned":false,"acquired":true,"shares":51697,"price":1.75,"value":90469.75,"ownership":{"direct":false,"nature":"By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $1.72 to $1.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":318418,"source":{"system":"sec-edgar","filing":"0001868726-24-000094","document":"wk-form4_1732050250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000186872624000094/wk-form4_1732050250.xml","form_type":"4"}},{"id":1358794,"issuer":{"id":31605,"kind":"organization","name":"OLAPLEX HOLDINGS, INC.","symbol":"OLPX"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-19T21:04:17.000Z","date":"2024-11-15","kind":"purchase","planned":false,"acquired":true,"shares":25128,"price":1.76,"value":44225.28,"ownership":{"direct":false,"nature":"By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $1.75 to $1.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":266721,"source":{"system":"sec-edgar","filing":"0001868726-24-000094","document":"wk-form4_1732050250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000186872624000094/wk-form4_1732050250.xml","form_type":"4"}},{"id":1364161,"issuer":{"id":2309,"kind":"organization","name":"TAPESTRY, INC.","symbol":"TPR"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-15T21:38:17.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":3459,"price":57.82,"value":199999.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 14, 2025."}],"balance_after":47846,"source":{"system":"sec-edgar","filing":"0001225208-24-009995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116132/000122520824009995/doc4.xml","form_type":"4"}},{"id":1393486,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-03T20:05:50.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":201,"price":105.24,"value":21153.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":32879,"source":{"system":"sec-edgar","filing":"0001225208-24-009087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520824009087/doc4.xml","form_type":"4"}},{"id":1426422,"issuer":{"id":31605,"kind":"organization","name":"OLAPLEX HOLDINGS, INC.","symbol":"OLPX"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-21T20:29:04.000Z","date":"2024-08-19","kind":"purchase","planned":false,"acquired":true,"shares":183493,"price":2.05,"value":376160.65,"ownership":{"direct":false,"nature":"By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $2.02 to $2.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":241593,"source":{"system":"sec-edgar","filing":"0001868726-24-000073","document":"wk-form4_1724272137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000186872624000073/wk-form4_1724272137.xml","form_type":"4"}},{"id":1436783,"issuer":{"id":31605,"kind":"organization","name":"OLAPLEX HOLDINGS, INC.","symbol":"OLPX"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-09T20:03:00.000Z","date":"2024-08-08","kind":"grant","planned":false,"acquired":true,"shares":203046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the conditional right to receive one share of Common Stock. The RSUs will vest in full on July 16, 2025, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":345903,"source":{"system":"sec-edgar","filing":"0001868726-24-000057","document":"wk-form4_1723233773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000186872624000057/wk-form4_1723233773.xml","form_type":"4"}},{"id":1461852,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-03T21:26:42.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":222,"price":95.61,"value":21225.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":32521,"source":{"system":"sec-edgar","filing":"0001225208-24-007283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520824007283/doc4.xml","form_type":"4"}},{"id":1516884,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-15T20:08:21.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":2201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Annual director stock option grant under the issuer's incentive compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2024 grant date."}],"balance_after":2201,"derivative":{"exercise_price":94.46,"expiration_date":"2032-05-13","underlying":"Common Stock","underlying_shares":2201},"source":{"system":"sec-edgar","filing":"0001225208-24-006064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520824006064/doc4.xml","form_type":"4"}},{"id":1516883,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-15T20:08:21.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":1905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan."}],"balance_after":32198,"source":{"system":"sec-edgar","filing":"0001225208-24-006064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520824006064/doc4.xml","form_type":"4"}},{"id":1530050,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-03T20:04:12.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":false,"shares":6329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options awarded under the issuer's incentive compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option became exercisable in one-third increments beginning on the first anniversary of the May 14, 2018 grant date."}],"balance_after":0,"derivative":{"exercise_price":62.04,"expiration_date":"2024-05-14","underlying":"Common Stock","underlying_shares":6329},"source":{"system":"sec-edgar","filing":"0001225208-24-005537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520824005537/doc4.xml","form_type":"4"}},{"id":1530049,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-03T20:04:12.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":6329,"price":91.5936,"value":579695.8944,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan."}],"balance_after":30236,"source":{"system":"sec-edgar","filing":"0001225208-24-005537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520824005537/doc4.xml","form_type":"4"}},{"id":1530048,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-03T20:04:12.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":6329,"price":62.04,"value":392651.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options awarded under the issuer's incentive compensation plan."}],"balance_after":36565,"source":{"system":"sec-edgar","filing":"0001225208-24-005537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520824005537/doc4.xml","form_type":"4"}},{"id":1552384,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-03T20:15:33.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":240,"price":88.36,"value":21206.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":30236,"source":{"system":"sec-edgar","filing":"0001225208-24-004870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520824004870/doc4.xml","form_type":"4"}},{"id":1690416,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-04T21:16:40.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":271,"price":78.18,"value":21186.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":29829,"source":{"system":"sec-edgar","filing":"0001225208-24-000383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520824000383/doc4.xml","form_type":"4"}},{"id":1723618,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-04T22:36:20.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":20374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors."}],"balance_after":60231,"source":{"system":"sec-edgar","filing":"0001415889-23-015788","document":"form4-12042023_101213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588923015788/form4-12042023_101213.xml","form_type":"4"}},{"id":1750146,"issuer":{"id":2309,"kind":"organization","name":"TAPESTRY, INC.","symbol":"TPR"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option","published_at":"2023-11-03T21:48:00.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":10302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"All of these securities acquired were issued under the Issuer's Stock Incentive Plan."}],"balance_after":10302,"derivative":{"exercise_price":27.33,"exercise_date":"2024-11-02","expiration_date":"2033-11-02","underlying":"Common Stock","underlying_shares":10302},"source":{"system":"sec-edgar","filing":"0001225208-23-009971","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1116132/000122520823009971/doc4.xml","form_type":"4"}},{"id":1750145,"issuer":{"id":2309,"kind":"organization","name":"TAPESTRY, INC.","symbol":"TPR"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-03T21:48:00.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":3110,"price":27.33,"value":84996.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 2, 2024."}],"balance_after":44282,"source":{"system":"sec-edgar","filing":"0001225208-23-009971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116132/000122520823009971/doc4.xml","form_type":"4"}},{"id":1766353,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-04T20:20:06.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":292,"price":72.76,"value":21245.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":29375,"source":{"system":"sec-edgar","filing":"0001225208-23-009323","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520823009323/doc4.xml","form_type":"4"}},{"id":1771957,"issuer":{"id":3700,"kind":"organization","name":"CAMPBELL'S Co","symbol":"CPB"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2023-09-29T20:08:36.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":1642.03,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Phantom Stock is the economic equivalent of one share of issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom shares are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The value of Phantom Stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 163.60 shares acquired through dividend reinvestment since the reporting person's last report."}],"balance_after":22065.49,"derivative":{"underlying":"Common Stock","underlying_shares":1642.03},"source":{"system":"sec-edgar","filing":"0000016732-23-000124","document":"wk-form4_1696018105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/16732/000001673223000124/wk-form4_1696018105.xml","form_type":"4"}},{"id":1778758,"issuer":{"id":31605,"kind":"organization","name":"OLAPLEX HOLDINGS, INC.","symbol":"OLPX"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T21:16:20.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":8100,"price":2.29,"value":18549.0,"ownership":{"direct":false,"nature":"By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $2.29 to $2.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":58100,"source":{"system":"sec-edgar","filing":"0001868726-23-000084","document":"wf-form4_169507176842816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000186872623000084/wf-form4_169507176842816.xml","form_type":"4"}},{"id":1807204,"issuer":{"id":31605,"kind":"organization","name":"OLAPLEX HOLDINGS, INC.","symbol":"OLPX"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-15T20:10:59.000Z","date":"2023-08-15","kind":"purchase","planned":false,"acquired":true,"shares":43500,"price":2.63,"value":114405.0,"ownership":{"direct":false,"nature":"By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $2.59 to $2.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001868726-23-000081","document":"wf-form4_169213024439745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000186872623000081/wf-form4_169213024439745.xml","form_type":"4"}},{"id":1807203,"issuer":{"id":31605,"kind":"organization","name":"OLAPLEX HOLDINGS, INC.","symbol":"OLPX"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-15T20:10:59.000Z","date":"2023-08-14","kind":"purchase","planned":false,"acquired":true,"shares":6500,"price":2.65,"value":17225.0,"ownership":{"direct":false,"nature":"By the Amended and Restated John P. Bilbrey Revocable Declaration of Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $2.64 to $2.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001868726-23-000081","document":"wf-form4_169213024439745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000186872623000081/wf-form4_169213024439745.xml","form_type":"4"}},{"id":1810710,"issuer":{"id":31605,"kind":"organization","name":"OLAPLEX HOLDINGS, INC.","symbol":"OLPX"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-10T20:09:38.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":142857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the conditional right to receive one share of Common Stock. The RSUs will vest in full on July 9, 2024, subject to the Reporting Person's continued service to the Issuer through such vesting date."}],"balance_after":142857,"source":{"system":"sec-edgar","filing":"0001868726-23-000075","document":"wf-form4_169169815147137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000186872623000075/wf-form4_169169815147137.xml","form_type":"4"}},{"id":1834860,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-06T20:08:47.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":278,"price":76.32,"value":21216.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":28907,"source":{"system":"sec-edgar","filing":"0001225208-23-007357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520823007357/doc4.xml","form_type":"4"}},{"id":1841751,"issuer":{"id":3700,"kind":"organization","name":"CAMPBELL'S Co","symbol":"CPB"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2023-06-30T19:17:42.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":1489.67,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Phantom Stock is the economic equivalent of one share of issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom shares are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The value of Phantom Stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 126.27  shares acquired through dividend reinvestment since the reporting person's last report."}],"balance_after":20259.86,"derivative":{"underlying":"Common Stock","underlying_shares":1489.67},"source":{"system":"sec-edgar","filing":"0000016732-23-000092","document":"wk-form4_1688152653.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/16732/000001673223000092/wk-form4_1688152653.xml","form_type":"4"}},{"id":1890828,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-17T20:07:32.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":2884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Annual director stock option grant under the issuer's incentive compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 15, 2023 grant date."}],"balance_after":2884,"derivative":{"exercise_price":81.08,"expiration_date":"2031-05-15","underlying":"Common Stock","underlying_shares":2884},"source":{"system":"sec-edgar","filing":"0001225208-23-005993","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520823005993/doc4.xml","form_type":"4"}},{"id":1890827,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-17T20:07:32.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":2220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan."}],"balance_after":28628,"source":{"system":"sec-edgar","filing":"0001225208-23-005993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520823005993/doc4.xml","form_type":"4"}},{"id":1899056,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-10T20:23:04.000Z","date":"2023-05-09","kind":"exercise","planned":false,"acquired":false,"shares":5703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options awarded under the issuer's incentive compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option became exercisable in one-third increments beginning on the first anniversary of the May 15, 2017 grant date."}],"balance_after":0,"derivative":{"exercise_price":71.65,"expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":5703},"source":{"system":"sec-edgar","filing":"0001225208-23-005681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520823005681/doc4.xml","form_type":"4"}},{"id":1899055,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-10T20:23:04.000Z","date":"2023-05-09","kind":"sale","planned":false,"acquired":false,"shares":5703,"price":80.8116,"value":460868.5548,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Weighted average price, as these shares were sold in multiple transactions at prices ranging from $80.81 to $80.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":26257,"source":{"system":"sec-edgar","filing":"0001225208-23-005681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520823005681/doc4.xml","form_type":"4"}},{"id":1899054,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-10T20:23:04.000Z","date":"2023-05-09","kind":"exercise","planned":false,"acquired":true,"shares":5703,"price":71.65,"value":408619.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options awarded under the issuer's incentive compensation plan."}],"balance_after":31960,"source":{"system":"sec-edgar","filing":"0001225208-23-005681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520823005681/doc4.xml","form_type":"4"}},{"id":1926333,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-05T20:21:30.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":291,"price":72.95,"value":21228.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":26257,"source":{"system":"sec-edgar","filing":"0001225208-23-004677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520823004677/doc4.xml","form_type":"4"}},{"id":1934649,"issuer":{"id":3700,"kind":"organization","name":"CAMPBELL'S Co","symbol":"CPB"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2023-03-31T20:53:53.000Z","date":"2023-03-30","kind":"grant","planned":false,"acquired":true,"shares":1245.4,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Phantom Stock is the economic equivalent of one share of issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom shares are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 123.16 shares acquired through dividend reinvestment since the reporting person's last report."}],"balance_after":18643.92,"derivative":{"underlying":"Common Stock","underlying_shares":1245.4},"source":{"system":"sec-edgar","filing":"0000016732-23-000043","document":"wf-form4_168029601878233.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/16732/000001673223000043/wf-form4_168029601878233.xml","form_type":"4"}},{"id":2065176,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-05T21:17:38.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":271,"price":78.4,"value":21246.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":25809,"source":{"system":"sec-edgar","filing":"0001225208-23-000400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520823000400/doc4.xml","form_type":"4"}},{"id":2072342,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-01-03T22:08:18.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":722.8584,"price":12.22,"value":8833.329648,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.22 on December 30, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":14487.3487,"derivative":{"underlying":"Common Stock","underlying_shares":722.8584},"source":{"system":"sec-edgar","filing":"0001415889-23-000089","document":"form4-01032023_100159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588923000089/form4-01032023_100159.xml","form_type":"4"}},{"id":2073964,"issuer":{"id":3700,"kind":"organization","name":"CAMPBELL'S Co","symbol":"CPB"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2023-01-03T21:13:35.000Z","date":"2022-12-29","kind":"grant","acquired":true,"shares":1161.61,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Phantom Stock is the economic equivalent of one share of issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom shares are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 111.90 shares acquired through dividend reinvestment since the reporting person's last report."}],"balance_after":17275.36,"derivative":{"underlying":"Common Stock","underlying_shares":1161.61},"source":{"system":"sec-edgar","filing":"0000016732-23-000019","document":"wf-form4_167278040173970.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/16732/000001673223000019/wf-form4_167278040173970.xml","form_type":"4"}},{"id":2098005,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-12-02T22:03:29.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":686.3504,"price":12.87,"value":8833.329648,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F3","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":13764.4903,"derivative":{"underlying":"Common Stock","underlying_shares":686.3504},"source":{"system":"sec-edgar","filing":"0001415889-22-011971","document":"form4-12022022_101218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588922011971/form4-12022022_101218.xml","form_type":"4"}},{"id":2098004,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-02T22:03:29.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":18649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors."}],"balance_after":39857,"source":{"system":"sec-edgar","filing":"0001415889-22-011971","document":"form4-12022022_101218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588922011971/form4-12022022_101218.xml","form_type":"4"}},{"id":2114920,"issuer":{"id":2309,"kind":"organization","name":"TAPESTRY, INC.","symbol":"TPR"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option","published_at":"2022-11-16T22:52:37.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":6822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"All of the securities acquired were issued under the Issuer's Stock Incentive Plan."}],"balance_after":6822,"derivative":{"exercise_price":34.98,"exercise_date":"2023-11-15","expiration_date":"2032-11-15","underlying":"Common Stock","underlying_shares":6822},"source":{"system":"sec-edgar","filing":"0001225208-22-011757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1116132/000122520822011757/doc4.xml","form_type":"4"}},{"id":2114919,"issuer":{"id":2309,"kind":"organization","name":"TAPESTRY, INC.","symbol":"TPR"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-11-16T22:52:37.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":2430,"price":34.98,"value":85001.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 15, 2023."}],"balance_after":41088,"source":{"system":"sec-edgar","filing":"0001225208-22-011757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116132/000122520822011757/doc4.xml","form_type":"4"}},{"id":2115963,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-15T21:40:21.000Z","date":"2022-11-11","kind":"purchase","acquired":true,"shares":7500,"price":13.2356,"value":99267.0,"ownership":{"direct":false,"nature":"Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average price of 7,500 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on November 11, 2022 with purchase prices ranging from $13.22 to $13.27 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":41722,"source":{"system":"sec-edgar","filing":"0001415889-22-011397","document":"form4-11152022_091113.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588922011397/form4-11152022_091113.xml","form_type":"4"}},{"id":2126990,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-11-02T20:32:20.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":669.699,"price":13.19,"value":8833.32981,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $13.19 on October 31, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":13078.1399,"derivative":{"underlying":"Common Stock","underlying_shares":669.699},"source":{"system":"sec-edgar","filing":"0001415889-22-011004","document":"form4-11022022_011109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588922011004/form4-11022022_011109.xml","form_type":"4"}},{"id":2143368,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-10-06T00:00:59.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":280,"price":75.71,"value":21198.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":25384,"source":{"system":"sec-edgar","filing":"0001225208-22-010844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520822010844/doc4.xml","form_type":"4"}},{"id":2144076,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-10-04T21:54:07.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":711.7913,"price":12.41,"value":8833.330033,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.41 on September 30, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":12408.4409,"derivative":{"underlying":"Common Stock","underlying_shares":711.7913},"source":{"system":"sec-edgar","filing":"0001415889-22-010281","document":"form4-10042022_021043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588922010281/form4-10042022_021043.xml","form_type":"4"}},{"id":2149159,"issuer":{"id":3700,"kind":"organization","name":"CAMPBELL'S Co","symbol":"CPB"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2022-09-30T20:14:55.000Z","date":"2022-09-29","kind":"grant","acquired":true,"shares":1401.3,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Phantom Stock is the economic equivalent of one share of issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom shares are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 108.15 shares acquired through dividend reinvestment since the reporting person's last report."}],"balance_after":16001.85,"derivative":{"underlying":"Common Stock","underlying_shares":1401.3},"source":{"system":"sec-edgar","filing":"0000016732-22-000112","document":"wf-form4_166456888006759.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/16732/000001673222000112/wf-form4_166456888006759.xml","form_type":"4"}},{"id":2167278,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-09-02T20:05:43.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":583.8288,"price":15.13,"value":8833.329744,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $15.13 on August 31, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":11696.6496,"derivative":{"underlying":"Common Stock","underlying_shares":583.8288},"source":{"system":"sec-edgar","filing":"0001415889-22-009256","document":"form4-09022022_010925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588922009256/form4-09022022_010925.xml","form_type":"4"}},{"id":2197341,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-08-02T20:34:10.000Z","date":"2022-07-29","kind":"grant","acquired":true,"shares":435.9985,"price":20.26,"value":8833.32961,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.26 on July 29, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.26 on July 29, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":11112.8208,"derivative":{"underlying":"Common Stock","underlying_shares":435.9985},"source":{"system":"sec-edgar","filing":"0001415889-22-008115","document":"form4-08022022_010800.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588922008115/form4-08022022_010800.xml","form_type":"4"}},{"id":2213682,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-07-06T21:05:30.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":273,"price":77.62,"value":21190.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":24963,"source":{"system":"sec-edgar","filing":"0001225208-22-008663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520822008663/doc4.xml","form_type":"4"}},{"id":2214321,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-07-05T20:33:53.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":449.9913,"price":19.63,"value":8833.329219,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $19.63 on June 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $19.63 on June 30, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":10676.8223,"derivative":{"underlying":"Common Stock","underlying_shares":449.9913},"source":{"system":"sec-edgar","filing":"0001415889-22-007339","document":"form4-07052022_010732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588922007339/form4-07052022_010732.xml","form_type":"4"}},{"id":2218424,"issuer":{"id":3700,"kind":"organization","name":"CAMPBELL'S Co","symbol":"CPB"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2022-07-01T14:19:44.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":1361.05,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Phantom Stock is the economic equivalent of one share of issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom shares are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 102.78 shares acquired through dividend reinvestment since the reporting person's last report."}],"balance_after":14492.4,"derivative":{"underlying":"Common Stock","underlying_shares":1361.05},"source":{"system":"sec-edgar","filing":"0000016732-22-000056","document":"wf-form4_165668517190927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/16732/000001673222000056/wf-form4_165668517190927.xml","form_type":"4"}},{"id":2247210,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-06-02T23:53:25.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":372.7143,"price":23.7,"value":8833.32891,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.70 on May 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.70 on May 31, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":10226.831,"derivative":{"underlying":"Common Stock","underlying_shares":372.7143},"source":{"system":"sec-edgar","filing":"0001415889-22-006045","document":"form4-06022022_040611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588922006045/form4-06022022_040611.xml","form_type":"4"}},{"id":2271786,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T21:59:38.000Z","date":"2022-05-11","kind":"purchase","acquired":true,"shares":10000,"price":22.0284,"value":220284.0,"ownership":{"direct":false,"nature":"Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average price of  10,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on May 11, 2022 with purchase prices ranging from $21.98 to $22.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":34222,"source":{"system":"sec-edgar","filing":"0001415889-22-004968","document":"form4-05132022_020509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588922004968/form4-05132022_020509.xml","form_type":"4"}},{"id":2275690,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-11T20:32:05.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":3122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Annual director stock option grant under the issuer's incentive compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 9, 2022 grant date."}],"balance_after":3122,"derivative":{"exercise_price":77.67,"expiration_date":"2030-05-09","underlying":"Common Stock","underlying_shares":3122},"source":{"system":"sec-edgar","filing":"0001225208-22-006880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520822006880/doc4.xml","form_type":"4"}},{"id":2275689,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-11T20:32:05.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":2317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan."}],"balance_after":24565,"source":{"system":"sec-edgar","filing":"0001225208-22-006880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520822006880/doc4.xml","form_type":"4"}},{"id":2283965,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-05-03T21:30:08.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":349.0055,"price":25.31,"value":8833.329205,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $25.31 on April 29, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $25.31 on April 29, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":9854.1167,"derivative":{"underlying":"Common Stock","underlying_shares":349.0055},"source":{"system":"sec-edgar","filing":"0001415889-22-004543","document":"form4-05032022_020557.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588922004543/form4-05032022_020557.xml","form_type":"4"}},{"id":2307795,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-04-04T21:55:27.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":338.5714,"price":26.09,"value":8833.327826,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.09 on March 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.09 on March 31, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":9505.1112,"derivative":{"underlying":"Common Stock","underlying_shares":338.5714},"source":{"system":"sec-edgar","filing":"0001415889-22-003756","document":"form4-04042022_020413.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000141588922003756/form4-04042022_020413.xml","form_type":"4"}},{"id":2310538,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-04-04T20:34:29.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":283,"price":75.16,"value":21270.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":22248,"source":{"system":"sec-edgar","filing":"0001225208-22-005405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520822005405/doc4.xml","form_type":"4"}},{"id":2312388,"issuer":{"id":3700,"kind":"organization","name":"CAMPBELL'S Co","symbol":"CPB"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2022-04-01T20:38:09.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":1493.76,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Phantom Stock is the economic equivalent of one share of issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom shares are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 95.93 shares acquired through dividend reinvestment since the reporting person's last report."}],"balance_after":13028.56,"derivative":{"underlying":"Common Stock","underlying_shares":1493.76},"source":{"system":"sec-edgar","filing":"0000016732-22-000030","document":"wf-form4_164884547647523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/16732/000001673222000030/wf-form4_164884547647523.xml","form_type":"4"}},{"id":2360052,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-03-02T22:48:41.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":310.9233,"price":28.41,"value":8833.330953,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.41 on February 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.41 on February 28, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":9166.5398,"derivative":{"underlying":"Common Stock","underlying_shares":310.9233},"source":{"system":"sec-edgar","filing":"0001179110-22-001940","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000117911022001940/edgar.xml","form_type":"4"}},{"id":2396860,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T22:29:04.000Z","date":"2022-02-14","kind":"exercise","acquired":false,"shares":5389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options awarded under the issuer's incentive compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option became exercisable in one-third increments beginning on the first anniversary of the May 9, 2016 grant date."}],"balance_after":0,"derivative":{"exercise_price":71.76,"expiration_date":"2022-05-09","underlying":"Common Stock","underlying_shares":5389},"source":{"system":"sec-edgar","filing":"0001225208-22-002185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520822002185/doc4.xml","form_type":"4"}},{"id":2396859,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-02-15T22:29:04.000Z","date":"2022-02-14","kind":"sale","acquired":false,"shares":4917,"price":78.6603,"value":386772.6951,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale of shares with proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Weighted average price, as these shares were sold in multiple transactions at prices ranging from $78.660 to $78.665, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":21849,"source":{"system":"sec-edgar","filing":"0001225208-22-002185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520822002185/doc4.xml","form_type":"4"}},{"id":2396858,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-02-15T22:29:04.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":5389,"price":71.76,"value":386714.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options awarded under the issuer's incentive compensation plan."}],"balance_after":26766,"source":{"system":"sec-edgar","filing":"0001225208-22-002185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520822002185/doc4.xml","form_type":"4"}},{"id":2416181,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-02-03T01:36:02.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":339.2215,"price":26.04,"value":8833.32786,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.04 on January 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $26.04 on January 31, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":8855.6165,"derivative":{"underlying":"Common Stock","underlying_shares":339.2215},"source":{"system":"sec-edgar","filing":"0001179110-22-000723","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000117911022000723/edgar.xml","form_type":"4"}},{"id":2446927,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-01-05T21:55:11.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":262,"price":81.13,"value":21256.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":21377,"source":{"system":"sec-edgar","filing":"0001225208-22-000481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520822000481/doc4.xml","form_type":"4"}},{"id":2448239,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-01-04T22:48:58.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":311.2519,"price":28.38,"value":8833.328922,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":8516.395,"derivative":{"underlying":"Common Stock","underlying_shares":311.2519},"source":{"system":"sec-edgar","filing":"0001179110-22-000131","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000117911022000131/edgar.xml","form_type":"4"}},{"id":2456693,"issuer":{"id":3700,"kind":"organization","name":"CAMPBELL'S Co","symbol":"CPB"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2021-12-30T19:59:17.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":1524.18,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Phantom Stock is the economic equivalent of one share of issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom shares are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 89.96 shares acquired through dividend reinvestment since the reporting person's last report."}],"balance_after":11438.87,"derivative":{"underlying":"Common Stock","underlying_shares":1524.18},"source":{"system":"sec-edgar","filing":"0000016732-21-000185","document":"wf-form4_164089434372379.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/16732/000001673221000185/wf-form4_164089434372379.xml","form_type":"4"}},{"id":2488447,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-12-02T22:15:46.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":307.3532,"price":28.74,"value":8833.330968,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F3","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":8205.1431,"derivative":{"underlying":"Common Stock","underlying_shares":307.3532},"source":{"system":"sec-edgar","filing":"0001179110-21-010539","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000117911021010539/edgar.xml","form_type":"4"}},{"id":2488446,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-02T22:15:46.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":7307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors."}],"balance_after":21208,"source":{"system":"sec-edgar","filing":"0001179110-21-010539","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000117911021010539/edgar.xml","form_type":"4"}},{"id":2523286,"issuer":{"id":2309,"kind":"organization","name":"TAPESTRY, INC.","symbol":"TPR"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option","published_at":"2021-11-05T20:21:14.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":5523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"All of the securities acquired were issued under the Issuer's Stock Incentive Plan."}],"balance_after":5523,"derivative":{"exercise_price":41.82,"exercise_date":"2022-11-03","expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":5523},"source":{"system":"sec-edgar","filing":"0001225208-21-013631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1116132/000122520821013631/doc4.xml","form_type":"4"}},{"id":2523285,"issuer":{"id":2309,"kind":"organization","name":"TAPESTRY, INC.","symbol":"TPR"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-11-05T20:21:14.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":1793,"price":41.82,"value":74983.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 3, 2022."}],"balance_after":38603,"source":{"system":"sec-edgar","filing":"0001225208-21-013631","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1116132/000122520821013631/doc4.xml","form_type":"4"}},{"id":2528438,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-11-02T20:28:53.000Z","date":"2021-10-29","kind":"grant","acquired":true,"shares":217.9644,"price":32.88,"value":7166.669472,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":7897.7899,"derivative":{"underlying":"Common Stock","underlying_shares":217.9644},"source":{"system":"sec-edgar","filing":"0001179110-21-009767","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000117911021009767/edgar.xml","form_type":"4"}},{"id":2551019,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-05T22:30:43.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":276,"price":76.91,"value":21227.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":20997,"source":{"system":"sec-edgar","filing":"0001225208-21-012941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520821012941/doc4.xml","form_type":"4"}},{"id":2551646,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-10-04T20:20:07.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":224.731,"price":31.89,"value":7166.67159,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.89 on September 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.89 on September 30, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":7679.8255,"derivative":{"underlying":"Common Stock","underlying_shares":224.731},"source":{"system":"sec-edgar","filing":"0001179110-21-009150","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000117911021009150/edgar.xml","form_type":"4"}},{"id":2555531,"issuer":{"id":3700,"kind":"organization","name":"CAMPBELL'S Co","symbol":"CPB"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2021-10-01T21:05:05.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":1537.34,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Phantom Stock is the economic equivalent of one share of issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom shares are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 70.20 shares acquired through dividend reinvestment since the reporting person's last report."}],"balance_after":9824.73,"derivative":{"underlying":"Common Stock","underlying_shares":1537.34},"source":{"system":"sec-edgar","filing":"0000016732-21-000109","document":"wf-form4_163312229284147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/16732/000001673221000109/wf-form4_163312229284147.xml","form_type":"4"}},{"id":2581366,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-09-02T20:25:00.000Z","date":"2021-08-31","kind":"grant","acquired":true,"shares":214.6995,"price":33.38,"value":7166.66931,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $33.38 on August 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $33.38 on August 31, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":7455.0675,"derivative":{"underlying":"Common Stock","underlying_shares":214.6995},"source":{"system":"sec-edgar","filing":"0001235110-21-000029","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000123511021000029/edgar.xml","form_type":"4"}},{"id":2617301,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-08-03T20:43:13.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":196.5086,"price":36.37,"value":7147.017782,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $36.37 on July 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $36.37 on July 30, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":7240.368,"derivative":{"underlying":"Common Stock","underlying_shares":196.5086},"source":{"system":"sec-edgar","filing":"0000950138-21-000402","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000095013821000402/edgar.xml","form_type":"4"}},{"id":2643290,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-06T21:28:00.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":258,"price":82.33,"value":21241.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors."}],"balance_after":20610,"source":{"system":"sec-edgar","filing":"0001225208-21-010309","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520821010309/doc4.xml","form_type":"4"}},{"id":2644091,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-07-02T20:48:26.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":206.5918,"price":34.69,"value":7166.669542,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $34.69 on June 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $34.69 on June 30, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":7043.8594,"derivative":{"underlying":"Common Stock","underlying_shares":206.5918},"source":{"system":"sec-edgar","filing":"0000950138-21-000372","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000095013821000372/edgar.xml","form_type":"4"}},{"id":2649226,"issuer":{"id":3700,"kind":"organization","name":"CAMPBELL'S Co","symbol":"CPB"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2021-07-01T20:44:02.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":1443.68,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Phantom Stock is the economic equivalent of one share of issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom shares are fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 51.39 shares acquired through dividend reinvestment since the reporting person's last report."}],"balance_after":8217.19,"derivative":{"underlying":"Common Stock","underlying_shares":1443.68},"source":{"system":"sec-edgar","filing":"0000016732-21-000079","document":"wf-form4_162517213767690.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/16732/000001673221000079/wf-form4_162517213767690.xml","form_type":"4"}},{"id":2686132,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-06-02T20:50:14.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":199.1848,"price":35.98,"value":7166.669104,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"security","element":"securityTitle","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $35.98 on May 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $35.98 on May 28, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the \"Plan\") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock."}],"balance_after":6837.2676,"derivative":{"underlying":"Common Stock","underlying_shares":199.1848},"source":{"system":"sec-edgar","filing":"0000950138-21-000315","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1268386/000095013821000315/edgar.xml","form_type":"4"}},{"id":2717914,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-12T21:03:37.000Z","date":"2021-05-10","kind":"grant","acquired":true,"shares":3611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Annual director stock option grant under the issuer's incentive compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 10, 2021 grant date."}],"balance_after":3611,"derivative":{"exercise_price":83.34,"expiration_date":"2029-05-10","underlying":"Common Stock","underlying_shares":3611},"source":{"system":"sec-edgar","filing":"0001225208-21-008044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520821008044/doc4.xml","form_type":"4"}},{"id":2717913,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-12T21:03:37.000Z","date":"2021-05-10","kind":"grant","acquired":true,"shares":2159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan."}],"balance_after":20245,"source":{"system":"sec-edgar","filing":"0001225208-21-008044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520821008044/doc4.xml","form_type":"4"}},{"id":2724582,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-07T21:11:08.000Z","date":"2021-05-05","kind":"exercise","acquired":false,"shares":4652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options awarded under the issuer's incentive compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option became exercisable in one-third increments beginning on the first anniversary of the May 11, 2015 grant date."}],"balance_after":0,"derivative":{"exercise_price":67.83,"expiration_date":"2021-05-11","underlying":"Common Stock","underlying_shares":4652},"source":{"system":"sec-edgar","filing":"0001225208-21-007751","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520821007751/doc4.xml","form_type":"4"}},{"id":2724581,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-07T21:11:08.000Z","date":"2021-05-05","kind":"sale","acquired":false,"shares":3941,"price":80.95,"value":319023.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale of shares with proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan."}],"balance_after":18086,"source":{"system":"sec-edgar","filing":"0001225208-21-007751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520821007751/doc4.xml","form_type":"4"}},{"id":2724580,"issuer":{"id":2972,"kind":"organization","name":"COLGATE PALMOLIVE CO","symbol":"CL"},"owners":[{"id":31658,"kind":"person","name":"BILBREY JOHN P","position":1,"cik":"0001268386","reported_name":"BILBREY JOHN P","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-07T21:11:08.000Z","date":"2021-05-05","kind":"exercise","acquired":true,"shares":4652,"price":67.83,"value":315545.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise of stock options awarded under the issuer's incentive compensation plan."}],"balance_after":22027,"source":{"system":"sec-edgar","filing":"0001225208-21-007751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/21665/000122520821007751/doc4.xml","form_type":"4"}}],"next_cursor":"2021-05-07T21:11:08.000000Z,2724580"}